Breast cancer screening is often treated as a given. Mammograms are framed as routine, early detection as unquestionably life-saving, and following guidelines as the responsible choice. But what if the full picture is more complicated?

In this episode of hol+, Dr. Taz sits down with integrative oncologist and breast surgeon Dr. Jenn Simmons, author of The Smart Woman's Guide to Breast Cancer, to explore what breast cancer screening data actually shows, where common narratives may oversimplify reality, and how statistics can sometimes be misunderstood by both patients and providers.

Together, they discuss the difference between screening and diagnostic imaging, why detecting more cancers does not always mean fewer deaths, and how concepts like overdiagnosis and lead-time bias shape our interpretation of outcomes. Dr. Jenn also explains how breast cancer behaves differently from many other cancers, why progression is not always linear, and what tumor markers like ER, PR, HER2, and triple-negative really indicate.

The conversation expands beyond imaging into a whole-body view of breast health, touching on inflammation, immune function, metabolic health, toxic burden, stress, and lifestyle as factors that shape cancer risk and recovery. Rather than promoting fear or urgency, this episode focuses on helping listeners understand their bodies, ask better questions, and make informed decisions with clarity.

This episode is for anyone who wants a deeper understanding of breast cancer screening, feels overwhelmed by conflicting guidance, or wants to approach breast health with more nuance and less panic.

About Dr. Jenn Simmons

Dr. Jenn Simmons is an integrative oncologist, breast surgeon, and founder of Real Health MD. She was Philadelphia’s first fellowship-trained breast surgeon and spent nearly two decades leading one of the region’s top breast programs before transitioning into integrative oncology.

Drawing from her experience in conventional cancer care and her own health journey, Dr. Simmons now focuses on whole-body approaches to breast health, cancer prevention, and recovery, including metabolic health, inflammation, immune function, lifestyle medicine, and root-cause healing. She is the author of The Smart Woman's Guide to Breast Cancer, a patient-centered resource designed to help women better understand their diagnosis, ask informed questions, and navigate treatment decisions with clarity rather than fear.

Order the Book

The Smart Woman's Guide to Breast Cancer 

Stay Connected:

Connect further to Hol+ at https://holplus.co/- Don’t forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.

Follow Dr. Jenn Simmons
Instagram: https://www.instagram.com/drjennsimmons
YouTube: https://www.youtube.com/@dr.jennsimmons
Website: https://www.jennsimmonsmd.com/

Follow Dr. Taz on Instagram: 

https://www.instagram.com/drtazmd/

https://www.instagram.com/liveholplus/

Subscribe to the audio podcast: https://holplus.transistor.fm/subscribe

Subscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcasts

Get your copy of The Hormone Shift: Balance Your Body and Thrive Through Midlife and Menopause

Host & Production Team

Host: Dr. Taz; Produced by ClipGrowth.com (Producer: Pat Gostek)

00:00 Swedish trial claim and overdiagnosis framing
00:52 Why this became a part two conversation
03:25 Reframing screening narratives and medical training gaps
04:39 Why Dr. Simmons questions mammograms as a screening tool
06:06 Origins of screening programs and “invitation to screen” bias
07:12 Relative risk vs absolute numbers example (4 vs 5 per 1,000)
08:49 Overdiagnosis explained with a vivid analogy
09:50 Autopsy-study claim and the “microscopic cancer” idea
12:11 Swedish trial claim revisited: more diagnoses, same deaths
13:38 Downstream harms: callbacks, biopsies, overtreatment
15:04 Lead-time bias and survival statistics explained
16:44 Dr. Simmons’ view on the founder’s regret narrative
18:16 Switzerland headline clarified and what actually changed
20:10 Cautionary stories and aggressive cancers discussion
22:07 Why breast cancer does not always progress linearly
24:21 Buckets: DCIS, invasive, inflammatory, receptor types
26:15 Clinical vs subclinical disease approach
28:25 Long-term tradeoffs and “forgotten woman” after treatment
32:15 What ER PR HER2 mean biologically and system incentives
35:33 Testosterone discussion and prevention claim presented
42:15 Hormones after breast cancer and the 4-year “reintroduction” idea
44:29 Triple negative: environment, toxicity, immune system focus
49:19 What to do next: pause, exceptions, whole-body workup
52:32 Prevention and breast health approach begins
53:24 At-home tears test explanation (as discussed)
56:24 Detox basics and why sweating is emphasized
59:34 Imaging preferences for screening and what to do if limited access